VEA
BCYC

Virtus ETF Advisers’s Bicycle Therapeutics BCYC Stock Holding History

Virtus ETF Advisers’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,535
Closed -$49.5K – 466
2024
Q4 		$49.5K Sell
3,535
-254
-7% -$5.44K 0.02% 458
2024
Q3 		$85.7K Buy
3,789
+64
+2% +$1.48K 0.04% 402
2024
Q2 		$75.4K Sell
3,725
-2,049
-35% -$46.3K 0.04% 424
2024
Q1 		$144K Sell
5,774
-398
-6% -$8.45K 0.08% 332
2023
Q4 		$112K Buy
6,172
+2,467
+67% +$40.8K 0.07% 326
2023
Q3 		$74.4K Sell
3,705
-369
-9% -$8.44K 0.05% 375
2023
Q2 		$104K Buy
4,074
+929
+30% +$21.6K 0.06% 363
2023
Q1 		$66.9K Sell
3,145
-1,216
-28% -$30.5K 0.04% 408
2022
Q4 		$129K Sell
4,361
-3,648
-46% -$97.9K 0.07% 390
2022
Q3 		$186K Buy
8,009
+63
+0.8% +$1.5K 0.07% 327
2022
Q2 		$133K Buy
7,946
+4,959
+166% +$105K 0.05% 342
2022
Q1 		$131K Sell
2,987
-179
-6% -$8.36K 0.06% 246
2021
Q4 		$193K Sell
3,166
-3,964
-56% -$219K 0.07% 221
2021
Q3 		$297K Sell
7,130
-379
-5% -$13.3K 0.13% 202
2021
Q2 		$228K Buy
+7,509
New +$227K 0.09% 248

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Virtus ETF Advisers's BCYC Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Bicycle Therapeutics (BCYC) in Q1 2025, closing a stake of 3,535 shares — an estimated $49.5K sold.

Virtus ETF Advisers first reported a position in BCYC in Q2 2021 and held it in 15 quarters. The position peaked at $297K in Q3 2021. 95 funds tracked by Wall St. Rank hold BCYC as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Bicycle Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 3,535 Bicycle Therapeutics shares in Q1 2025, an estimated $49.5K.
  • Virtus ETF Advisers first reported a position in Bicycle Therapeutics in Q2 2021 and held it in 15 quarters.
  • Virtus ETF Advisers's Bicycle Therapeutics position peaked at $297K in Q3 2021.
  • 95 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.